Your session is about to expire
← Back to Search
Optune Device for Meningioma
Study Summary
This trial is testing a device called Optune to see if it's effective in treating meningiomas. The device is experimental and has not been approved by the FDA.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My recent scans show my tumor is growing.My steroid dose has been stable or reduced for at least 5 days.I have recovered from recent surgery for my recurring condition and it's been over 28 days since the operation.I am 18 years old or older.You have a ventricular shunt or catheter.You have something inside your head, like a piece of a bullet.I have a brain tumor below the tentorium, possibly with another growing above it.I have been cancer-free for at least 3 years, except for non-melanoma skin cancer or cervical carcinoma in-situ.I have symptoms or signs of high pressure inside my skull.Patients must have a tumor or abnormal tissue that can be measured to be at least 1cm x 1cm on a medical scan.I am not pregnant or breastfeeding and agree to use effective birth control.I am currently suffering from a severe infection.I have a part of my skull missing.I have had radiation for meningioma and my tumor has grown since then.I have had any number of surgeries, radiation, or chemotherapy treatments.My brain tumor is a grade II or III meningioma.I can care for myself but may need occasional help.It has been at least 4 weeks since my last cancer treatment.I have NF and any brain tumors I have haven't grown in the last 6 months.Your blood takes longer to clot than normal.I am not on any other clinical trials except for those focused on supportive care or quality of life.You have very low platelet or neutrophil counts in your blood.
- Group 1: Optune (NovoTTF-100A)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this trial currently accepting new participants?
"As noted on clinicaltrials.gov, this particular trial is no longer recruiting participants - its first posting was on June 1st 2013 and it last updated July 1st 2022. There are still 438 other studies actively seeking volunteers at the moment though."
How widely dispersed is the access to this research initiative?
"At present, 9 distinct sites are welcoming participants. Among them are Cincinnati, Miami and Denver with other locations spread across the country. For convenience, it is advantageous to choose a clinic closest to your home in order to limit any necessary travel arrangements if you join the trial."
Share this study with friends
Copy Link
Messenger